Summary:

2020 – present:  Assistant Professor and Principal Investigator  at Faculty of Veterinary Medicine, University of Lisbon, Portugal.

10/2019 – 12/2019: Visiting Scientist (Ira Pastan Lab) at the National Cancer Institute (NCI), National Health Institute, Bethesda, USA.

2019 – present: Co-founder and executive board member of the Collaborative Laboratory (Co-Lab) Vector B2B. The Vector B2B is a non-profit association between 4 academic research institutions (FMV, FF, FM, FC) and 3 companies (TechnoPhage, Medinfar, Bevag) that was approved by the Fundação para a Ciencia e Tecnologia (FCT) Co-Lab program. Vector B2B aims to provide highly qualified human resources in Portugal with knowledge and experience in the discovery and development of biotherapeutic molecules from bench to bedside.

2015 – present: Member of CIISA’s Coordination Committee at Faculty of Veterinary Medicine, University of Lisbon, Portugal.

2013 – 2018:  Principal Investigator under the FCT Starting Grants Program at Faculty of Veterinary Medicine, University of Lisbon, Portugal.

2013 – present: Scientific Adviser at Technoantibodies (TechnoPhage SA).

2008 – 2012: Co-founder and Scientific Manager at TechnoAntibodies (Technophage SA).

2004 – 2008: Ph.D in Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Portugal. Research studies were performed at Faculty of Pharmacy, Portugal (Joao Gonçalves Lab), Scripps Research Institute, USA (Carlos Barbas Lab) and National Institute of Health, USA (Robert Craigie Lab).

2002 – 2004: Master’s degree in advanced Biomolecular Methods, University of Aveiro, Portugal.

1996 – 2001: BSc in Biotechnology Engineering, University of Algarve, Portugal.